05 Compliance

The regulatory file for glucosamine hydrochloride

Technical document 05 · Reviewed 2026-11-19 · Glucosamine

On this page
  1. The layers of a market file
  2. European Union
  3. United States
  4. Contaminants and the finished-dose calculation
  5. Label names and claims
  6. Documents that travel with the lot
  7. Checklist before the first order

Glucosamine hydrochloride is sold as a food or dietary-supplement ingredient in many markets, and the route differs by destination. The supplier's file can name the frameworks and provide the lot documents, but the determination belongs to the buyer's regulatory team: a certificate describes the powder, not the permission to sell it.

In one line

The material is the same in every market; the route, the limits and the label are not, and the buyer's regulatory team owns that determination.

The layers of a market file

A market file is assembled in layers. The material layer is the specification: the salt, the CAS number, the source and the revision being bought. The lot layer is the certificate and the retained sample. The destination layer is the route, the limits and the label. The change layer is what happens when the source, process or pack changes. A supplier can fill the first two; the third belongs to the buyer; the fourth belongs to both, because a source change rewrites the allergen statement.

Form and source both belong in the file, not in a footnote. A dossier written around glucosamine hydrochloride does not cover a sulfate complex or N-acetyl glucosamine, because the ingredient name, the counter-ion and the mass per serving change. A shellfish-derived lot carries a crustacean declaration that a fermentation-derived lot does not. Keep the three facts, form, source and specification revision, together with dated documents.

European Union

For a food-supplement application in the EU, the instruments to read are Regulation (EC) No 178/2002 on general food law and Directive 2002/46/EC on food supplements, together with Regulation (EU) No 1169/2011 on food information to consumers. Contaminants sit under Commission Regulation (EU) 2023/915, and claims under Regulation (EC) No 1924/2006. The consolidated text in force is the reference; a trade summary is not.

Two questions need the buyer's answer rather than the supplier's assurance. Whether the destination permits this ingredient, and on which basis, is a determination for the buyer's regulatory team; this page does not assert a novel-food authorisation, and Regulation (EU) 2015/2283 is the framework to test if the status is in doubt. Whether the crustacean allergen must be emphasised depends on the source: shrimp or crab shell requires the Annex II declaration under Regulation (EU) No 1169/2011, while a fermentation-derived lot has no crustacean entry but still needs an accurate source statement and a documented allergen assessment.

United States

In the United States, the usual route is a dietary supplement under DSHEA, the Dietary Supplement Health and Education Act of 1994. The definitions sit in section 201(ff) of the Federal Food, Drug, and Cosmetic Act, manufacturing in 21 CFR Part 111, and the Supplement Facts panel in 21 CFR 101.36. A new dietary ingredient notification under 21 U.S.C. 350b may be relevant; whether it applies is for the buyer's regulatory team to determine, and this page asserts neither a notification nor a pre-DSHEA status.

The panel names the ingredient as sold, so “glucosamine hydrochloride” rather than “glucosamine”, and a sulfate complex should carry its counter-ion in the name. A shellfish-derived ingredient needs the US allergen declaration, and the source statement should sit on the label or in the material the brand relies on. Claims are reviewed apart from the certificate, and the finished product's category is a separate legal question from the specification of the drum.

Contaminants and the finished-dose calculation

The catalog limits are measured on the drum. A destination limit usually applies to the finished product as sold, so the file has to carry the arithmetic from the ingredient result to the daily dose. At 3 mg/kg, a 1,500 mg dose brings 4.5 µg of lead; a 500 mg dose brings 1.5 µg. That conversion is where a compliant lot and a compliant product can part company.

Contaminant references to confirm for the destination
ElementReference levelWhat the finished-product file shows
Lead (Pb)3.0 mg/kg in the EU food supplementLot result, method and dose calculation
Cadmium (Cd)1.0 mg/kg, with category exceptions to checkLot result and the exception relied on
Mercury (Hg)0.10 mg/kg in the EU food supplementLot result and method
Arsenic (As)Buyer or market limitAgreed figure and method, stated on the certificate

US federal law sets no general elemental limit for dietary supplements in the way the EU contaminant regulation does. There the limit comes from the buyer's specification, the testing obligation under 21 CFR Part 111 and any state rule such as California's Proposition 65. For a US shipment, the specification is the controlling document, and the method and reporting limit deserve as much attention as the result.

Label names and claims

The declaration follows the salt. “Glucosamine hydrochloride”, “glucosamine sulfate” with its counter-ion, and “N-acetyl glucosamine” are three declarations, and wording built for one does not transfer. In the EU, a claim must appear in the Register under Regulation (EC) No 1924/2006 with its conditions attached, and the reviewer checks the entry rather than a paraphrase. In the US, a structure/function claim carries the DSHEA disclaimer, while a disease claim would move the product into a different regulatory category.

No claim for the ingredient is made on this page, and this page is not a label. The brand's reviewer confirms the wording, the form and the market before artwork is signed off; a certificate does not approve a claim.

Documents that travel with the lot

  • Lot certificate with methods, limits and results.
  • Specification and technical data sheet at the agreed revision.
  • Safety data sheet for handling and transport.
  • Source and origin declaration: shellfish or fermentation, and the country of origin.
  • Allergen declaration, including the crustacean statement where the source requires it.
  • GMO, residual-solvent and non-irradiation statements; halal or kosher certificates on request.
  • Elemental and microbiological results, and the stability summary for the pack being bought.

Checklist before the first order

  • The purchase order names the salt, the CAS number and the source.
  • The specification revision on file matches the certificate and the quotation.
  • The allergen declaration matches the source, and the artwork carries it.
  • The elemental results have been converted to the finished daily dose.
  • The destination route and the label wording have been confirmed by the buyer's regulatory team.
  • Change control covers a source switch, a process change and a pack change.

The catalog specification is on the glucosamine product page; the lot tests are on the COA page; the analytical evidence is on the identity page. The EU regulatory note and the US regulatory note give the framework references, and the quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation